SINOPEGのビジョンは科学企業であり、革新的な材料と技術を提供して、患者の治療の質を向上させ、人間の健康を改善するための現在の治療改善と新しい治療法の開発についてお客様と提携しています
もっと調べるIn Vivo Gene Editing Therapies Offer Root-Cause Treatment for Genetic Diseases, but Efficient and Precise Liver-Targeted Delivery Remains a Critical Hurdle for Clinical Translation. Lipid Nanoparticles (LNPs), as the Mainstream Non-Viral Vector, Have...
In the biopharmaceutical field, PEGylation technology continues to attract significant industry attention as a key means of improving drug performance. Sinopeg has deep expertise in the PEG derivative sector and is committed to providing pharmaceutic...
In recent years, mRNA technology has demonstrated broad application prospects in vaccine development, protein replacement therapy, and tumor immunotherapy, owing to its flexible sequence design and high expression efficiency. However, overcoming the ...